CD44 and hyaluronan promote the bone morphogenetic protein 7 signaling response in murine chondrocytes

Arthritis and Rheumatology

Volumn 66, Issue 6, 2014, Pages 1547-1558

  Luo, Na ^a,b   Knudson, Warren ^a   Askew, Emily B ^a   Veluci, Roberta ^a   Knudson, Cheryl B ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIDASE; HYMECROMONE; MESSENGER RNA; OSTEOGENIC PROTEIN 1; SMAD1 PROTEIN;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AGGRECANS; ANIMALS; ANTIGENS, CD44; BONE MORPHOGENETIC PROTEIN 7; CELLS, CULTURED; CHONDROCYTES; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; TRANSFECTION;

EID: 84901626580     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38388     Document Type: Article

References (50)

1. Umulis D, O'Connor MB, Blair SS,. The extracellular regulation of bone morphogenetic protein signaling. Development 2009; 136: 3715-28.
2. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B,. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303-13.
3. Ponta H, Sherman L, Herrlich P,. CD44: From adhesion molecules to signaling regulators. Nature Rev Mol Cell Biol 2003; 4: 33-45.
4. Lokeshwar VB, Fregien N, Bourguignon LY,. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J Cell Biol 1994; 126: 1099-109.
5. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A,. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 1994; 126: 391-401.
6. Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA, et al. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 2001; 15: 968-80.
7. Sohara Y, Ishiguro N, Machida K, Kurata H, Thant AA, Senga T, et al. Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner. Mol Biol Cell 2001; 12: 1859-68.
8. Turley EA, Noble PW, Bourguignon LY,. Signaling properties of hyaluronan receptors. J Biol Chem 2002; 277: 4589-92.
9. Peterson RS, Andhare RA, Rousche KT, Knudson W, Wang W, Grossfield JB, et al. CD44 modulates Smad1 activation in the BMP-7 signaling pathway. J Cell Biol 2004; 166: 1081-91.
10. Reddi A,. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotech 1998; 16: 247-52.
11. Andhare RA, Takahashi N, Knudson W, Knudson CB,. Hyaluronan promotes the chondrocyte response to BMP-7. Osteoarthritis Cartilage 2009; 17: 892-902.
12. Nishida Y, Knudson CB, Nietfeld JJ, Margulis A, Knudson W,. Antisense inhibition of hyaluronan synthase-2 in human articular chondrocytes inhibits proteoglycan retention and matrix assembly. J Biol Chem 1999; 274: 21893-9.
13. Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL,. SARA, a FYVE domain protein that recruits Smad2 to the TGFβ receptor. Cell 1998; 95: 779-91.
14. Massague J, Seoane J, Wotton D,. Smad transcription factors. Genes Dev 2005; 19: 2783-810.
15. Flechtenmacher J, Huch K, Thonar EJ, Mollenhauer JA, Davies SR, Schmid TM, et al. Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis Rheum 1996; 39: 1896-904.
16. Nishida Y, Knudson CB, Eger W, Kuettner KE, Knudson W,. Osteogenic protein 1 stimulates cell-associated matrix assembly by normal human articular chondrocytes: up-regulation of hyaluronan synthase, CD44, and aggrecan. Arthritis Rheum 2000; 43: 206-14.
17. Wu G, Hunziker EB, Zheng Y, Wismeijer D, Liu Y,. Functionalization of deproteinized bovine bone with a coating-incorporated depot of BMP-2 renders the material efficiently osteoinductive and suppresses foreign-body reactivity. Bone 2011; 49: 1323-30.
18. Xiao Z, Watson N, Rodriguez C, Lodish HF,. Nucleocytoplasmic shuttling of Smad1 conferred by its nuclear localization and nuclear export signals. J Biol Chem 2001; 276: 39404-10.
19. Yang S, Zhong C, Frenkel B, Reddi AH, Roy-Burman P,. Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Res 2005; 65: 5769-77.
20. Draffin JE, McFarlane S, Hill A, Johnston PG, Waugh DJ,. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res 2004; 64: 5702-11.
21. Lou W, Krill D, Dhir R, Becich MJ, Dong JT, Frierson HF, et al. Methylation of the CD44 metastasis suppressor gene in human prostate cancer. Cancer Res 1999; 59: 2329-31.
22. Schmits R, Filmus J, Gerwin N, Senaldi G, Kiefer F, Kundig T, et al. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 1997; 90: 2217-33.
23. Protin U, Schweighoffer T, Jochum W, Hilberg F,. CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. J Immunol 1999; 163: 4917-23.
24. Szanto S, Gal I, Gonda A, Glant TT, Mikecz K,. Expression of L-selectin, but not CD44, is required for early neutrophil extravasation in antigen-induced arthritis. J Immunol 2004; 172: 6723-34.
25. Ohno S, Im HJ, Knudson CB, Knudson W,. Hyaluronan oligosaccharides induce matrix metalloproteinase 13 via transcriptional activation of NFκB and p38 MAP kinase in articular chondrocytes. J Biol Chem 2006; 281: 17952-60.
26. Knudson W, Aguiar DJ, Hua Q, Knudson CB,. CD44-anchored hyaluronan-rich pericellular matrices: an ultrastructural and biochemical analysis. Exp Cell Res 1996; 228: 216-28.
27. Takahashi N, Knudson CB, Thankamony S, Ariyoshi W, Mellor L, Im HJ, et al. Induction of CD44 cleavage in articular chondrocytes. Arthritis Rheum 2010; 62: 1338-48.
28. Ghatak S, Misra S, Toole BP,. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem 2002; 277: 38013-20.
29. Ariyoshi W, Knudson CB, Luo N, Fosang AJ, Knudson W,. Internalization of aggrecan G1 domain neoepitope ITEGE in chondrocytes requires CD44. J Biol Chem 2010; 285: 36216-24.
30. Jiang H, Peterson RS, Wang W, Bartnik E, Knudson CB, Knudson W,. A requirement for the CD44 cytoplasmic domain for hyaluronan binding, pericellular matrix assembly and receptor mediated endocytosis in COS-7 cells. J Biol Chem 2002; 277: 10531-8.
31. Salvat C, Pigenet A, Humbert L, Berenbaum F, Thirion S,. Immature murine articular chondrocytes in primary culture: a new tool for investigating cartilage. Osteoarthritis Cartilage 2005; 13: 243-9.
32. Oreffo RO, Cooper C, Mason C, Clements M,. Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential. Stem Cell Rev 2005; 1: 169-78.
33. Schmitz I, Ariyoshi W, Takahashi N, Knudson CB, Knudson W,. Hyaluronan oligosaccharide treatment of chondrocytes stimulates expression of both HAS-2 and MMP-3, but by different signaling pathways. Osteoarthritis Cartilage 2010; 18: 447-54.
34. Meran S, Luo D, Simpson R, Martin J, Wells A, Steadman R, et al. Hyaluronan facilitates transforming growth factor-β1- dependent proliferation via CD44 and epidermal growth factor receptor interaction. J Biol Chem 2011; 286: 17618-30.
35. 2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem 2006; 281: 14026-40.
36. Macias-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL,. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J Biol Chem 1998; 273: 25628-36.
37. Aoki H, Fujii M, Imamura T, Yagi K, Takehara K, Kato M, et al. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J Cell Sci 2001; 114: 1483-9.
38. Lavery K, Swain P, Falb D, Alaoui-Ismaili MH,. BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. J Biol Chem 2008; 283: 20948-58.
39. Kakizaki I, Kojima K, Takagaki K, Endo M, Kannagi R, Ito M, et al. A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone. J Biol Chem 2004; 279: 33281-9.
40. Kultti A, Pasonen-Seppanen S, Jauhiainen M, Rilla KJ, Karna R, Pyoria E, et al. 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. Exp Cell Res 2009; 315: 1914-23.
41. Good MC, Zalatan JG, Lim WA,. Scaffold proteins: hubs for controlling the flow of cellular information. Science 2011; 332: 680-6.
42. Yang C, Cao M, Liu H, He Y, Xu J, Du Y, et al. The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. J Biol Chem 2012; 287: 43094-107.
43. Miyazono K, Kamiya Y, Morikawa M,. Bone morphogenetic protein receptors and signal transduction. J Biochem 2010; 147: 35-51.
44. Fisher MC, Li Y, Seghatoleslami M, Dealy CN, Kosher RA,. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation. Matrix Biol 2006; 25: 27-39.
45. Rilla K, Pasonen-Seppnen S, Deen AJ, Koistinen VV, Wojciechowski S, Oikari S, et al. Hyaluronan production enhances shedding of plasma membrane-derived microvesicles. Exp Cell Res 2013; 319: 2006-18.
46. Sugahara KN, Murai T, Nishinakamura H, Kawashima H, Saya H, Miyasaka M,. Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J Biol Chem 2003; 278: 32259-65.
47. Kuo W, Digman M, Lander AD,. Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero- oligomerization. Mol Biol Cell 2010; 21: 4028-41.
48. Chubinskaya S, Kumar B, Merrihew C, Heretis K, Rueger DC, Kuettner KE,. Age-related changes in cartilage endogenous osteogenic protein-1 (OP-1). Biochim Biophys Acta 2002; 1588: 126-34.
49. Lories RJ, Luyten FP,. Bone morphogenetic protein signaling in joint homeostasis and disease. Cytokine Growth Factor Rev 2005; 16: 287-98.
50. Nagano O, Saya H,. Mechanism and biological significance of CD44 cleavage. Cancer Sci 2004; 95: 930-5.